SINTX Regains Nasdaq Listing Compliance as Volume Spikes 5.9x
SINTX (SINT) volume surged 5.9x average after Nasdaq compliance news, but a -232% ROE and 9.2% EPS miss keep this micro-cap watchlist-only for now.
signal:SINT:2026-08-13 SINTX Regains Nasdaq Listing Compliance as Volume Spikes 5.9x
On August 13, SINTX Technologies confirmed it has regained compliance with Nasdaq's listing requirements, an announcement that landed just two days after its Q2 report and coincided with trading volume surging to 5.9x the 20-day average, suggesting the removal of delisting risk is what pulled renewed attention back to this micro-cap ceramics name. The core thesis here is straightforward: a binary listing-risk event has been resolved at the same moment the company posted a revenue beat, and the market is now repricing the stock around that cleared overhang rather than around any change in the underlying business.
The Q2 print itself was mixed rather than uniformly strong. Revenue of $452,000 beat the $406,667 estimate, but EPS of $(0.75) missed the $(0.6868) consensus by roughly 9.2%, a reminder that top-line momentum has not yet translated into a narrower bottom line.
Key Facts
| Stock name | SINT |
|---|---|
| Ticker | SINT |
| Market | NASDAQ |
| Sector | Unclassified |
| Volume (x average) | 5.9x |
| Signal price | $1.71 |
Sintx Technologies, Inc., formerly known as Amedica Corporation, is an advanced ceramics company that researches, develops, and commercializes medical devices made with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. Its product lineup spans monolithic solid and porous silicon nitride, silicon nitride powder and coatings, and composite materials incorporating polyether ether ketone (PEEK). Incorporated in 1996 and headquartered in Salt Lake City, Utah, the company remains a small, specialized materials-science player.
Recent Analyst Coverage
External analyst opinions (not investment advice): (2026-08-01)
| Strong Buy | 2 |
|---|---|
| Buy | 6 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
Peer Companies
IRIX, ICU, MODD, CYDX, CODX
Risk Factors
The financial profile behind this bounce is still fragile. Return on equity sits at -232%, the debt ratio is 116%, and EV/EBITDA is negative at -0.8x, all of which point to a company that is burning capital faster than it generates it. The 9.2% EPS miss in the same quarter that triggered this volume spike underscores that the path to profitability has not materially changed just because the listing issue was resolved.
Broader market conditions are calm for now: the VIX sits at 14.6, the 10-year Treasury yield is at 4.64% (up just 0.07 percentage points over the past month and trending sideways), the dollar index (DXY) is at 100.0 (down 0.8% over the past month, also sideways), and high-yield credit spreads (OAS) are flat at 2.71 percentage points. That stability means there is little macro cover being provided here — this move is being driven almost entirely by company-specific news, which also means it can reverse quickly on company-specific disappointment. Proximity to the August 13 options expiration adds another source of short-term volatility that is unrelated to the fundamentals.
Recent Disclosures
Recent News
- 2026-08-13 SINTX Technologies Regains Nasdaq Compliance
- 2026-08-11 Sintx Technologies, Inc. (SINT) Q2 2026 Earnings Call Prepared Remarks Transcript
- 2026-08-11 SINTX Technologies Q2 EPS $(0.75) Misses $(0.66) Estimate, Sales $452.000K Beat $406.667K Estimate
Earnings Trend
| Fiscal Year | Revenue | Net Income |
|---|---|---|
| 2023 | $3M | $-8M |
| 2024 | $3M | $-11M |
| 2025 | $1M | $-10M |
Pre-Trade Checklist
| Business & competitive edge understood | ✅ Company profile summarized above |
|---|---|
| Leading sector | ⚠️ Not flagged as a leading sector |
| Good news already priced in? | ⚠️ Insufficient valuation data to judge |
| Stop-loss / take-profit set | ✅ Stop-loss -10% / first take-profit +20% set in advance |
| Exit plan if wrong | ✅ 10% trailing stop from peak; setup auto-invalidated on a break below key support |
Trade Levels
| Signal price | $1.71 |
|---|---|
| Stop-loss | $1.54 (-10% from signal price) |
| First take-profit | $2.05 (+20% from signal price) |
| Trailing stop | 10% from peak |
| Invalidation | Close back below key support ($1.64) |
With the signal price at $1.71, a stop-loss at $1.54 (-10%), and a first take-profit target of $2.05 (+20%) followed by a 10% trailing stop from the peak, this is a name to keep on the watchlist rather than to chase — a close back below the $1.64 support level would undercut the thesis and warrant a step back regardless of these levels.